This week in charts: 3 drug launches Wall Street is watching
The latest installment in BioPharma Dive’s visualization-focused series features a look at investors’ response to a trio of medicines highlighted in quarterly earnings this week.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.